Related references
Note: Only part of the references are listed.TGFBI expression is associated with a better response to chemotherapy in NSCLC
Marta Irigoyen et al.
MOLECULAR CANCER (2010)
Activated cAMP Response Element Binding Protein Is Overexpressed in Human Mesotheliomas and Inhibits Apoptosis
Arti Shukla et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Gene expression profiling in colorectal cancer using microarray technologies: Results and perspectives
Margherita Nannini et al.
CANCER TREATMENT REVIEWS (2009)
Down-Regulating Cold Shock Protein Genes Impairs Cancer Cell Survival and Enhances Chemosensitivity
Yu Zeng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
The multiplex bead array approach to identifying serum biomarkers associated with breast cancer
Byoung Kwon Kim et al.
BREAST CANCER RESEARCH (2009)
A comprehensive comparison of random forests and support vector machines for microarray-based cancer classification
Alexander Statnikov et al.
BMC BIOINFORMATICS (2008)
Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer
Lyndee L. Scurr et al.
CLINICAL CANCER RESEARCH (2008)
The Use of Genomics in Clinical Trial Design
Richard Simon
CLINICAL CANCER RESEARCH (2008)
Gene expression profiles as biomarkers for the prediction of chemotherapy drug response in human tumour cells
Amadeo M. Parissenti et al.
ANTI-CANCER DRUGS (2007)
Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan
Maguy Del Rio et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
被撤回的出版物: An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer (Retracted article. See vol. 30, pg. 678, 2012)
Holly K. Dressman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
Kenneth R. Hess et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gene selection and classification of microarray data using random forest -: art. no. 3
R Díaz-Uriarte et al.
BMC BIOINFORMATICS (2006)
Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers
A Berchuck et al.
CLINICAL CANCER RESEARCH (2005)
Tumor classification by tissue microarray profiling: random forest clustering applied to renal cell carcinoma
T Shi et al.
MODERN PATHOLOGY (2005)
Over-expression of TGF-beta I in Smad4-deficient human oral carcinoma cells causes tumour regression in vivo by mechanisms that sensitize cells to apoptosis
S Thavaraj et al.
JOURNAL OF PATHOLOGY (2005)
Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer
MS Braun et al.
BRITISH JOURNAL OF CANCER (2003)
Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data
BL Wu et al.
BIOINFORMATICS (2003)
Using gene expression ratios to predict outcome among patients with mesothelioma
GJ Gordon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling
Y Midorikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Sequential unfolding of ankyrin repeats in tumor suppressor p16
KS Tang et al.
STRUCTURE (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A 'modified de Gramont' regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer
SL Cheeseman et al.
BRITISH JOURNAL OF CANCER (2002)
Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase
Y Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-β signaling
X Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by Notch1
JC Aster et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
S Giacchetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
